Preoperative TACE with lenvatinib and PD-1 inhibitors in patients with CNLC stage Ib to IIIa hepatocellular carcinoma: a propensity multicenter score matched analysis

Hao Wu, Li Tong, Zhihua Yan, Hui Hou, Shengxue Xie, Qiru Xiong, Lian Yang, Kun Xie, Liquan Yu, Shubo Pan

Open source

DOI
10.1016/j.ejso.2026.112107
Published
2026-11
Container
European Journal of Surgical Oncology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ejso.2026.112107,
  title = {Preoperative TACE with lenvatinib and PD-1 inhibitors in patients with CNLC stage Ib to IIIa hepatocellular carcinoma: a propensity multicenter score matched analysis},
  author = {Hao Wu and Li Tong and Zhihua Yan and Hui Hou and Shengxue Xie and Qiru Xiong and Lian Yang and Kun Xie and Liquan Yu and Shubo Pan},
  year = {2026},
  journal = {European Journal of Surgical Oncology},
  doi = {10.1016/j.ejso.2026.112107},
  url = {https://doi.org/10.1016/j.ejso.2026.112107}
}

RIS

TY  - JOUR
TI  - Preoperative TACE with lenvatinib and PD-1 inhibitors in patients with CNLC stage Ib to IIIa hepatocellular carcinoma: a propensity multicenter score matched analysis
AU  - Hao Wu
AU  - Li Tong
AU  - Zhihua Yan
AU  - Hui Hou
AU  - Shengxue Xie
AU  - Qiru Xiong
AU  - Lian Yang
AU  - Kun Xie
AU  - Liquan Yu
AU  - Shubo Pan
PY  - 2026
JO  - European Journal of Surgical Oncology
DO  - 10.1016/j.ejso.2026.112107
UR  - https://doi.org/10.1016/j.ejso.2026.112107
ER  - 

APA

Wu, H., Tong, L., Yan, Z., Hou, H., Xie, S., Xiong, Q., Yang, L., Xie, K., Yu, L., & Pan, S. (2026). Preoperative TACE with lenvatinib and PD-1 inhibitors in patients with CNLC stage Ib to IIIa hepatocellular carcinoma: a propensity multicenter score matched analysis. European Journal of Surgical Oncology. https://doi.org/10.1016/j.ejso.2026.112107

Source records